Wedelolactone alleviates doxorubicin-induced inflammation and oxidative stress damage of podocytes by IκK/IκB/NF-κB pathway.
Zhu MM, Wang L, Yang D, Li C, Pang ST, Li XH, Li R, Yang B, Lian YP, Ma L, Lv QL, Jia XB, Feng L.
Zhu MM, et al. Among authors: li xh, li c, li r.
Biomed Pharmacother. 2019 Sep;117:109088. doi: 10.1016/j.biopha.2019.109088. Epub 2019 Jun 12.
Biomed Pharmacother. 2019.
PMID: 31202173
Free article.